ClinicalTrials.gg
CompletedNCT04319497Updated Mar 24, 2020

Subjective and Objective Refraction in Pseudophakic Patients

An interventional study of Subjective refraction and Autorefraction in Pseudophakia, sponsored by Vienna Institute for Research in Ocular Surgery. Completed at 1 site in Austria. Open to participants aged 21 Years to 105 Years. Per ClinicalTrials.gov, last updated 2020-03-24.

Sponsored by Vienna Institute for Research in Ocular Surgery · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 6 years 11 months after the study started (first participant enrolled Mar 2013, registered Mar 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
21 Years to 105 Years
Sex
All
01

Study summary

Targeting of post-cataract refraction depends mainly on the prediction of the post-operative lens position, but also on the post-operative refraction itself. Hence, aim of this study is to evaluate the agreement and variability of subjective refraction performed by two independent examiners, autorefraction, and wavefront aberrometry in pseudophakic patients after uneventful cataract surgery.

Read the detailed description

One of the main goals of modern cataract surgery, beside removing the cataractous lens, is to achieve the patient's desired post-operative refraction. Targeting this post-operative refraction depends mainly on the prediction of the post-operative lens position and the post-operative refraction itself. Reason for the contributing effect of post-operative refraction in the error-propagation analyses is that refraction in phakic patients was shown to have only moderate reproducibility.

In the past, different studies evaluated refraction methods. However, there is no study that included reproducibility of subjective refraction in pseudophakic patients and compares it with objective refraction methods (autorefraction, wavefront aberrometry).

100 eyes of 100 patients, which underwent uneventful cataract surgery, will be included in the study. Refraction of one eye of each patient will be tested using subjective refraction by two different examiners, autorefraction, and wavefront aberrometry at two separate occasions.

02

Conditions studied

  • Pseudophakia

Browse trials for

Keywords

  • Subjective Refraction
  • Autorefraction
  • Wavefront Aberrometry
03

In context

Pseudophakia

54 studies on the registry are indexed under Pseudophakia; 8 are open to participants now.

This study's enrollment of 100 is above the median of 45 across 25 interventional studies indexed under Pseudophakia.

Browse Pseudophakia studies →

Lead sponsor

Vienna Institute for Research in Ocular Surgery is the lead sponsor of 65 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 105 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Minimum age: 21 years
  • Cataract surgery (at least 8 weeks post-surgery)
  • written

Exclusion criteria

Exclusion Criteria:

  • Complications during or after cataract surgery
  • Ophthalmic diseases, that might interfere with measurements (macular degeneration, glaucoma, diabetic retinopathia)
  • Ophthalmic surgery other than cataract surgery
  • posterior capsule opacification
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Other
    Refraction reproducibility and agreement

    Subjective and objective refraction will be performed in all patients

    Device: Subjective refraction · Device: Autorefraction · Device: Wavefront aberrometry

Interventions

  • DeviceSubjective refraction

    Subjective refraction measurements will be performed by two testers for all the patients included

  • DeviceAutorefraction

    Five autorefraction measurements will be performed for all the patients included

  • DeviceWavefront aberrometry

    Five wavefront measurements will be performed for all the patients included

06

What researchers measure

Primary outcomes

  1. Evaluation of the agreement between the subjective refraction measurements (in dioptres) of two examiners

    To show the number of measurements within the limits of agreement, Bland-Altman plots will be created for subjective refraction measurements in dioptres between examiner 1 and examiner 2.

    Time frame: 12 months

Secondary outcomes

  1. Evaluation of reproducibility between the subjective refraction measurements between two study visits

    To compare reproducibility of subjective refraction measurements between study visit 1 and study visit 2 Wilcoxon-signed rank test will be applied.

    Time frame: 12 months

  2. Evaluation of the agreement between the measurements performed by subjective refraction, autorefraction, and wavefront aberrometry (in dioptres)

    To show the number of measurements within the limits of agreement, Bland-Altman plots will be created for subjective refraction measurements in dioptres between the 3 measurement methods.

    Time frame: 12 months

  3. Evaluation of the reproducibility between measurements done with subjective refraction, autorefraction, and wavefront aberrometry in dioptres

    To compare reproducibility between the 3 measurement methods in dioptres, Friedman's multiple comparison will be applied.

    Time frame: 12 months

07

Study locations

1 site
  • Vienna Institute for Research in Ocular Surgery (VIROS)
    Vienna, 1140, Austria
08

References and documents

Publications

  • Ruiss M, Findl O, Draschl P, Harrer-Seely A, Hirnschall N. Agreement and variability of subjective refraction, autorefraction, and wavefront aberrometry in pseudophakic patients. J Cataract Refract Surg. 2021 Aug 1;47(8):1056-1063. doi: 10.1097/j.jcrs.0000000000000583. PubMed 34292891 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04319497
Lead sponsor
Vienna Institute for Research in Ocular Surgery
Responsible party
Prim. Prof. Dr. Oliver Findl, MBA (Principal Investigator, Vienna Institute for Research in Ocular Surgery) — Principal investigator
First posted
Mar 24, 2020
Start date
Mar 20, 2013
Primary completion
Aug 20, 2014
Completion
Aug 20, 2014
Last update
Mar 24, 2020

Study contacts

Oliver Findl, Prof.
principal investigator · VIROS, Hanusch Hospital Vienna

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion